CABRI, WALTER
 Distribuzione geografica
Continente #
AS - Asia 5.635
NA - Nord America 5.473
EU - Europa 5.044
SA - Sud America 371
AF - Africa 325
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 4
Totale 16.862
Nazione #
US - Stati Uniti d'America 5.393
SG - Singapore 1.903
IT - Italia 1.893
CN - Cina 1.628
DE - Germania 755
IN - India 696
GB - Regno Unito 680
VN - Vietnam 494
SE - Svezia 442
HK - Hong Kong 422
RU - Federazione Russa 258
BR - Brasile 257
IE - Irlanda 189
FR - Francia 166
KR - Corea 156
NL - Olanda 119
UA - Ucraina 114
CI - Costa d'Avorio 103
TG - Togo 90
CH - Svizzera 73
JP - Giappone 70
FI - Finlandia 58
AR - Argentina 57
HR - Croazia 54
ID - Indonesia 52
CA - Canada 48
SC - Seychelles 46
ZA - Sudafrica 46
PL - Polonia 41
TW - Taiwan 36
AT - Austria 31
ES - Italia 31
JO - Giordania 30
TR - Turchia 26
MX - Messico 22
BE - Belgio 21
BG - Bulgaria 20
BD - Bangladesh 18
CL - Cile 18
DZ - Algeria 14
GR - Grecia 14
PK - Pakistan 14
IR - Iran 13
RO - Romania 12
EC - Ecuador 11
TH - Thailandia 11
CZ - Repubblica Ceca 10
DK - Danimarca 10
PT - Portogallo 10
AU - Australia 9
MY - Malesia 9
PY - Paraguay 9
CO - Colombia 8
EG - Egitto 8
LV - Lettonia 8
HU - Ungheria 7
PH - Filippine 7
AE - Emirati Arabi Uniti 6
EE - Estonia 6
NP - Nepal 6
SA - Arabia Saudita 6
LB - Libano 5
LT - Lituania 5
IL - Israele 4
MA - Marocco 4
MU - Mauritius 4
PE - Perù 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AL - Albania 3
BO - Bolivia 3
CY - Cipro 3
IQ - Iraq 3
SK - Slovacchia (Repubblica Slovacca) 3
VE - Venezuela 3
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
GE - Georgia 2
HN - Honduras 2
JM - Giamaica 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
MO - Macao, regione amministrativa speciale della Cina 2
PR - Porto Rico 2
PS - Palestinian Territory 2
RS - Serbia 2
SI - Slovenia 2
UG - Uganda 2
UZ - Uzbekistan 2
AM - Armenia 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
BZ - Belize 1
DJ - Gibuti 1
DM - Dominica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
EU - Europa 1
GI - Gibilterra 1
GN - Guinea 1
KG - Kirghizistan 1
Totale 16.851
Città #
Singapore 1.261
Chandler 613
Southend 543
Bologna 528
Santa Clara 517
Ashburn 497
Hong Kong 404
Hefei 339
Princeton 303
Fairfield 293
Beijing 236
Dublin 186
Boardman 180
Wilmington 180
Berlin 152
Dallas 149
Dong Ket 148
Seoul 143
Woodbridge 126
Seattle 115
Houston 113
Des Moines 109
Milan 107
Abidjan 103
Cambridge 100
Lomé 90
Los Angeles 82
Westminster 81
Medford 78
Buffalo 76
Redondo Beach 72
Hanoi 69
Ho Chi Minh City 67
Ann Arbor 63
Pune 63
Rome 56
Forlì 54
Hyderabad 53
Bengaluru 52
Tokyo 51
Chicago 50
Ferrara 50
New York 49
Duncan 48
Redwood City 45
Shanghai 44
Jinan 42
Guangzhou 40
São Paulo 40
Turin 40
Jakarta 39
Cesena 38
Helsinki 36
Florence 33
Olalla 33
Nanjing 32
Redmond 31
San Diego 31
Amman 30
Naples 29
Frankfurt am Main 28
Chengdu 27
Warsaw 27
Phoenix 25
Paris 24
Mumbai 23
Padova 23
Munich 22
Nuremberg 22
Delhi 21
Bern 20
London 20
Sofia 20
Bühl 19
Lavis 19
Tianjin 19
Zhengzhou 19
Chennai 18
Fisciano 18
Hangzhou 18
Montreal 18
Moscow 18
Taiyuan 18
Amsterdam 17
Council Bluffs 16
Hebei 16
Lappeenranta 16
Parma 16
Düsseldorf 15
Falkenstein 15
Shenyang 15
The Dalles 15
Boston 14
Denver 14
San Francisco 14
Vienna 14
Changsha 13
Salerno 13
Toronto 13
Zurich 13
Totale 9.967
Nome #
An Improved Process for the Preparation of Semaglutide Side Chain.” 426
Green Solvent Mixtures for Solid-Phase Peptide Synthesis: A Dimethylformamide-Free Highly Efficient Synthesis of Pharmaceutical-Grade Peptides 283
Replacing piperidine in Solid Phase Peptide Synthesis: effective Fmoc removal by alternative bases 278
Speeding up sustainable solution-phase peptide synthesis using T3P® as a green coupling reagent: methods and challenges 242
Fast Solution-Phase and Liquid-Phase Peptide Syntheses (SolPSS and LPPS) Mediated by Biomimetic Cyclic Propylphosphonic Anhydride (T3P®) 241
Ampicillin sodium: Isolation, identification and synthesis of the last unknown impurity after 60 years of clinical use 223
Method for the FMOC group cleavage 214
Pharmaceutical green chemistry in peptide synthesis A snapshot on the role of solvents in SPPS 213
Copper-Free Heck−Cassar−Sonogashira and Suzuki−Miyaura Reactions of Aryl Chlorides: A Sustainable Approach 210
Application of Af4-Multidetection to Liraglutide in Its Formulation: Preserving and Representing Native Aggregation 209
Process for the preparation of alectinib 202
Fast Heck−Cassar−Sonogashira (HCS) Reactions in Green Solvents 197
From green innovations in oligopeptide to oligonucleotide sustainable synthesis: differences and synergies in TIDES chemistry 189
Palladium Catalyst Recycling for Heck-Cassar-Sonogashira Cross-Coupling Reactions in Green Solvent/Base Blend 186
New Mechanistic Insights into the Copper-Free Heck-Cassar-Sonogashira Cross-Coupling Reaction 177
Fast MacMillan's Imidazolidinone-Catalyzed Enantioselective Synthesis of Polyfunctionalized 4-Isoxazoline Scaffolds 175
Steps towards sustainable solid phase peptide synthesis: use and recovery of N-octyl pyrrolidone 172
Carbodiimide-Mediated Beckmann Rearrangement of Oxyma-B as a Side Reaction in Peptide Synthesis 170
A translation of the twelve principles of green chemistry to guide the development of cross-coupling reactions 162
A Sustainable Chemo-Enzymatic Approach to the Synthesis of Liraglutide 160
Dimethyl carbonate as a green alternative to acetonitrile in reversed-phase liquid chromatography. Part I: Separation of small molecules 158
Process for the Synthesis of Propofol 154
Azetidinones as Zinc-Binding Groups to Design Selective HDAC8 Inhibitors 153
Green Chemistry Impact and Evolution in the Pharma Industry 152
Boosting basic-peptide separation through dynamic electrostatic-repulsion reversed-phase (d-ERRP) liquid chromatography 147
2-Azetidinones: synthesis of new bis(indolyl)butyl-beta-lactams 146
Biotechnological lycopene production by mated fermentation of Blakeslea trispora 136
Therapeutic Peptides Targeting PPI in Clinical Development: Overview, Mechanism of Action and Perspectives 135
Investigation of the GnRH antagonist degarelix isomerization in biological matrices 134
Novel insights into the chemistry of an old medicine: A general degradative pathway for penicillins from a piperacillin/tazobactam stability study 134
Benefits of a Mixed-Mode Stationary Phase to Address the Challenging Purification of an Industrially Relevant Peptide: A Proof-of-Concept Study 133
Blakeslea trispora genes for carotene biosynthesis 129
Process for the Synthesis, of Etelcacetide 128
Dimethyl carbonate as a green alternative to acetonitrile in reversed-phase liquid chromatography. Part II: purification of a therapeutic peptide 126
Process for the Synthesis of Nangibotide.” 126
Rediscovery of an Old Named Reaction: From Micellar Catalysis to Unusual Schotten−Baumann Conditions 124
Ganoderma lucidum Ethanol Extracts Enhance Re-Epithelialization and Prevent Keratinocytes from Free-Radical Injury 123
PROCESS FOR THE PREPARATION OF PROPOFOL 120
Aminocarnitine Ureidic Derivatives as Inhibitors of Carnitine Palmitoyltransferase I 120
Sustainability in peptide chemistry: current synthesis and purification technologies and future challenges. 120
Catalysis: A key technology for a green approach to pharmaceutical production 119
Development of a practical high-yield industrial synthesis of pergolide mesylate 119
Cefdinir: A comparative study of anhydrous vs. monohydrate form Microstructure and tabletting behaviour 117
100- “Biotransformation of Colchicinoids into Their Corresponding 3-O-Glucosyl Derivatives by Selected Strains of Bacillus megaterium 115
Thermodynamic and kinetic investigation of monoketo-aldehyde- peroxyhemiacetal (MKA), a stereolabile degradation product of dihydroartemisinin 114
Solid phase peptide synthesis using side-chain unprotected arginine and histidine with Oxyma Pure/TBEC in green solvents 113
Process Intensification for the Purification of Peptidomimetics: The Case of Icatibant through Multicolumn Countercurrent Solvent Gradient Purification (MCSGP) 111
An Improved Process for The Preparation of Ribociclib and its Salts 109
Overcoming chemical challenges in the solid-phase synthesis of high-purity GnRH antagonist Degarelix. Part 2 109
A Process for Preparing Alectinib or a Pharmaceutically Acceptable Salt Thereof 107
4,5,6,7-Tetrahydro-isoxazolo-[4,5-c]-pyridines as a new class of cytotoxic Hsp90 inhibitors. 107
High-throughput enantioseparation of Nα-fluorenylmethoxycarbonyl proteinogenic amino acids through fast chiral chromatography on zwitterionic-teicoplanin stationary phases 107
Understanding Glucagon Aggregation: In Silico Insights and Experimental Validation 104
From batch to continuous chromatographic purification of a therapeutic peptide through Multicolumn Countercurrent Solvent Gradient Purification (MCSGP) 104
Camptothecins in tumor homing via an RGD sequence mimetic 104
Process for the preparation of Degarelix 101
New Approach to Supramolecular Structure Determination in Pharmaceutical Preparation of Self-Assembling Peptides: A Case Study of Lanreotide Autogel 101
Stereolability of MKA, a rearrangement product of dihydroartemisinin endowed with antimalarian activity 100
A Process for the Preparing Treosulfan 100
a A Process For Purification of Carfilzomib Intermediate 100
Downstream Processing of Therapeutic Peptides by Means of Preparative Liquid Chromatography 100
Polymorphisms and patent, market, and legal battles: Cefdinir case study 99
Modeling the nonlinear behavior of a bioactive peptide in reversed-phase gradient elution chromatography 96
Process for the Manufacture of Derivatized Amino Acids 95
Reducing effect of the Chinese medicinal herb, Salvia miltiorrhiza, on alcohol self-administration in Sardinian alcohol-preferring rats” 95
CARBAMATE DERIVATIVES IN PARTICULAR FOR THE TREATMENT OF NEUROLOGICAL DISORDERS 94
Aryl isoxazole compounds with antitumoral Activities 94
On-column epimerization of dihydroartemisinin: An effective analytical approach to overcome the shortcomings of the International Pharmacopoeia monograph 94
Stereolability of Dihydroartemisinin, an Antimalarial Life-Saving Drug: a Comprehensive Kinetic Investigation - Part II 92
New approach to Tacrolimus Purification 92
Process for the manufacturing of glucagon.” 91
Catalysis: The pharmaceutical perspective 91
Expanding the Use of Dynamic Electrostatic Repulsion Reversed-Phase Chromatography: An Effective Elution Mode for Peptides Control and Analysis 91
An Improved Process For The Preparation of Sugammadex And Its Intermediates 89
Process for the Purification of Tacrolimus 89
Combination of HPLC "Inverted chirality columns approach" and MS/MS detection for extreme enantiomeric excess determination even in absence of reference samples. Application to camptothecin derivatives 89
Assessing the performance of new chromatographic technologies for the separation of peptide epimeric impurities: the case of Icatibant 89
omega-Alkoxy analogues of SAHA (vorinostat) as inhibitors of HDAC: A study of chain-length and stereochemical dependence 88
Synthesis and biological activity of fluorinated combretastatin analogues 88
Recovery of Bioactive Compounds from Artichokes Brines by nanofiltration 88
An Improved Process For The Preparation of Sugammadex Which Involves The Use of a Salt Of 3-mercapto Propionic Acid, Preferably The Di Sodium Salt Of 3-mercapto Propionic Acid 87
AMORPHOUS FORM OF A THIOCOLCHICINE DERIVATIVE 87
Production of peptides as generic drugs: a patent landscape of octeotride 86
Crystalline form of Cefdinir ammonium salt as an intermediate for the preparation of pure Cefdinir 85
Evolution of an acylase active on cephalosporin C 85
innovative chemical synthesis and conformational hits on the lipopeptide liraglutide 85
SUBTILISIN VARIANTS AND THEIR USE 83
ARYL TRIAZOLE COMPOUNDS WITH ANTITUMOURAL ACTIVITY 83
Industrial Synthesis Design With Low Environmental Impact In The Pharma Industry 83
Natural lycopene from Blakeslea trispora: all-trans lycopene thermochemical and structural properties 83
Investigating the Neuroprotective Effects of Turmeric Extract: Structural Interactions of β-Amyloid Peptide With Single Curcuminoids 82
Identification of a novel arylpiperazine scaffold for fatty acid amide hydrolase inhibition with improved drug disposition properties 82
ST7612AA1, a Thioacetate-ω(γ-lactam carboxamide) Derivative Selected from a Novel Generation of Oral HDAC Inhibitors 81
Peptide Drug Discovery and Process Development Perspectives 81
An Improved Process for the Preparation of Ixazomib citrate 80
Aminooxime derivatives of 2 and/or 4 substitued androstanes and androstenes as medicaments for cardiovascular disorders 80
Samital a new botanical drug for the treatment of mucosities induced by oncological therapies 80
Mastering palladium-catalyzed cross-coupling reactions: the critical role of in situ pre-catalyst reduction design 79
Improved process for the preparation of high purity glucagon 79
Epoxidation of 17-oxo-15,16-methylene steroids with sulfoxonium ylides 79
Totale 12.682
Categoria #
all - tutte 57.142
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.142


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.061 0 0 0 0 0 50 33 36 345 44 57 496
2021/20222.447 162 95 256 79 267 246 76 212 124 115 302 513
2022/20233.078 455 403 147 320 232 265 222 195 438 134 155 112
2023/20241.322 74 155 91 74 107 201 105 182 51 142 46 94
2024/20254.059 131 594 313 337 775 250 408 177 118 161 207 588
2025/20264.238 493 876 894 641 849 485 0 0 0 0 0 0
Totale 17.494